CSBR — CHAMPIONS ONCOLOGY INC (Healthcare >> Biotechnology)
CSBR FAQ
What is CSBR's P/E ratio?
CHAMPIONS ONCOLOGY INC (CSBR) currently trades at a P/E ratio of 298.17.
What is CSBR's ROE?
CHAMPIONS ONCOLOGY INC reports a Return on Equity (ROE) of -53.26%.
What is CSBR's dividend yield?
CHAMPIONS ONCOLOGY INC offers a dividend yield of 0.00%.
What is CSBR's Deepscope Quality Score?
Deepscope rates CSBR's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CSBR?
Deepscope's AI Timing Score for CSBR is 3 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CSBR belong to?
CHAMPIONS ONCOLOGY INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 6.50
Price
0.08
(1.25%)
Day Change
|
|
|---|
CSBR Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Tỷ lệ P/E tương đối cao
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt lắm , ...
| Yếu tố Chất lượng |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1816
|
| Magic Formula Rank by ROE |
1816
|
| Magic Formula Rank by ROIC |
1816
|
| Price | 6.50 |
| PBV / Sector |
20.36 / 4.91
|
| Earning Per Share | -0.17 |
| PE / Sector |
298.17 / 18.34
|
| PEG or PE/Growth / Sector |
-0.72 / 0.61
|
| Average 1M Daily Value |
0.05 M
GREAT
|
| Average 1W Daily Value |
0.04 M
GREAT
|
| Yếu tố Kỹ thuật |
|
85% |
| Sức khỏe tài chính |
|
45% |
| Khả năng kiếm lợi nhuận |
|
52% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-13 11:12:55 |
| Symbol | CSBR |
| Name | CHAMPIONS ONCOLOGY INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 13.89 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 89.15 / 9,034.83 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: One University Plaza, Hackensack, NJ, United States, 07601
Phone: 201 808 8400
Website: https://www.championsoncology.com
Employees: 213
Sector: Healthcare >> Biotechnology
Description: Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
Google